Straumann Holding Past Earnings Performance
Past criteria checks 1/6
Straumann Holding has been growing earnings at an average annual rate of 10.6%, while the Medical Equipment industry saw earnings growing at 3.9% annually. Revenues have been growing at an average rate of 12.7% per year. Straumann Holding's return on equity is 14.7%, and it has net margins of 11.3%.
Key information
10.6%
Earnings growth rate
10.5%
EPS growth rate
| Medical Equipment Industry Growth | -9.5% |
| Revenue growth rate | 12.7% |
| Return on equity | 14.7% |
| Net Margin | 11.3% |
| Next Earnings Update | 19 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Straumann Holding makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2,541 | 288 | 1,255 | 0 |
| 31 Mar 24 | 2,477 | 267 | 1,229 | 0 |
| 31 Dec 23 | 2,412 | 246 | 1,204 | 0 |
| 30 Sep 23 | 2,313 | 330 | 1,155 | 0 |
| 30 Jun 23 | 2,286 | 394 | 1,175 | 0 |
| 31 Mar 23 | 2,304 | 415 | 1,194 | 0 |
| 31 Dec 22 | 2,321 | 435 | 1,212 | 0 |
| 30 Sep 22 | 2,268 | 462 | 1,157 | 0 |
| 30 Jun 22 | 2,215 | 489 | 1,102 | 0 |
| 31 Mar 22 | 2,118 | 442 | 1,053 | 0 |
| 31 Dec 21 | 2,022 | 396 | 1,004 | 0 |
| 30 Sep 21 | 1,914 | 377 | 929 | 0 |
| 30 Jun 21 | 1,806 | 358 | 855 | 0 |
| 31 Mar 21 | 1,616 | 224 | 793 | 0 |
| 31 Dec 20 | 1,426 | 91 | 731 | 0 |
| 30 Sep 20 | 1,424 | 79 | 741 | 0 |
| 30 Jun 20 | 1,421 | 67 | 751 | 0 |
| 31 Mar 20 | 1,509 | 187 | 776 | 0 |
| 31 Dec 19 | 1,596 | 306 | 801 | 0 |
| 30 Sep 19 | 1,529 | 298 | 769 | 0 |
| 30 Jun 19 | 1,462 | 289 | 737 | 0 |
| 31 Mar 19 | 1,413 | 281 | 708 | 0 |
| 31 Dec 18 | 1,364 | 273 | 680 | 0 |
| 30 Sep 18 | 1,307 | 271 | 652 | 0 |
| 30 Jun 18 | 1,250 | 269 | 624 | 0 |
| 31 Mar 18 | 1,181 | 274 | 592 | 0 |
| 31 Dec 17 | 1,112 | 280 | 561 | 0 |
| 30 Sep 17 | 1,056 | 257 | 544 | 0 |
| 30 Jun 17 | 1,000 | 235 | 528 | 0 |
| 31 Mar 17 | 959 | 232 | 511 | 0 |
| 31 Dec 16 | 918 | 230 | 494 | 0 |
| 30 Sep 16 | 889 | 218 | 483 | 0 |
| 30 Jun 16 | 861 | 207 | 473 | 0 |
| 31 Mar 16 | 830 | 139 | 459 | 0 |
| 31 Dec 15 | 799 | 71 | 445 | 0 |
| 30 Sep 15 | 774 | 79 | 434 | 0 |
| 30 Jun 15 | 750 | 88 | 423 | 0 |
| 31 Mar 15 | 730 | 123 | 418 | 0 |
| 31 Dec 14 | 710 | 158 | 413 | 0 |
| 30 Sep 14 | 697 | 137 | 416 | 0 |
| 30 Jun 14 | 684 | 116 | 418 | 0 |
| 31 Mar 14 | 682 | 109 | 421 | 0 |
| 31 Dec 13 | 680 | 101 | 424 | 0 |
Quality Earnings: STMNZ has a large one-off loss of CHF171.4M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: STMNZ's current net profit margins (11.3%) are lower than last year (17.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: STMNZ's earnings have grown by 10.6% per year over the past 5 years.
Accelerating Growth: STMNZ's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: STMNZ had negative earnings growth (-27%) over the past year, making it difficult to compare to the Medical Equipment industry average (39.9%).
Return on Equity
High ROE: STMNZ's Return on Equity (14.7%) is considered low.